Advanced search
Publication Cover
International Reviews of Immunology Volume 21, 2002 - Issue 6
Submit an article Journal homepage
47
Views
21
CrossRef citations to date
0
Altmetric
Research Article

THE PROTECTIVE IMMUNE RESPONSE AGAINST VAGINAL CANDIDIASIS: LESSONS LEARNED FROM CLINICAL STUDIES AND ANIMAL MODELS

PAUL L. FIDEL Department of Microbiology, Immunology, and Parasitology,Louisiana State University Health Sciences Center, New Orleans, Louisiana
Pages 515-548 | Published online: 03 Aug 2009

  • J.D. Sobel, Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N.Y. Acad. Sci., 544: 547-557, 1988.
  • J.D. Sobel, Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis., 14: S148-S153, 1992.
  • H.L. Kent, Epidemiology of vaginitis. Am. J. Obstet. Gynecol., 165: 1168-1175, 1991.
  • F.C. Odds, Chronic mucocutaneous candidiosis. In Candida and Candidiasis, Baltimore, MD: University Park Press, p. 104, 1988.
  • M.E. Lynch, J.D. Sobel, and P.L. Fidel, Jr., Role of antifingal drug resistance in the pathogenesis of recurrent vulvovaginal candidasis. J. Med. Vet. Mycol. 34: 337-339, 1996.
  • J.F. Ryley and S. McGregor, Quantitation of vaginal Candida albicans infections in rodents. J. Med. Vet. Mycol, 24: 455-460, 1986.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun., 61: 1990-1995, 1993.
  • A. Valentin, C. Bernard, M. Mallie, M. Huerre, and J.M. Bastide, Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. Mycoses, 36: 379-384, 1993.
  • O.S. Kinsman and A.E. Collard, Hormonal factors in vaginal candidiasis in rats. Infect. Immun., 53: 498-504, 1986.
  • P.L. Fidel, Jr., J.L. Cutright, and C. Steele, Effects of reproductive hormones on experimental vaginal candidiasis. Infect. Immun., 68: 651-657, 2000.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Candida-specific Th1-type respon- siveness in mice with experimental vaginal candidiasis. Infect. Immun., 61: 4202-4207, 1993.
  • S. Mathur, R.S. Mathur, J.M. Goust, H.O. Williamson, and H.H. Fundenberg, Cyclic variations in white cell subpopulations in the human menstrual cycle: Correlations with progesterone and estradiol. Clin. Immunol. Immunopathol., 13: 246-253, 1979.
  • M. Klink, B. Rozalaska, and W. Rudnicka, Weakness of cellular response to Listeria antigens in pregnant mice [Polish]. Medycyna Doswiadczalna i Mikrobiologia, 45(1): 51-54, 1993.
  • D.N. Mazumder, N. Ghose, J. Mirta, G. Dutta, and A. Santra, Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis. Journal of the Indian Medical Association, 88(5): 129-131, 1990.
  • A. Cassone, M. Boccanera, D.A. Adriani, G. Santoni, and F. De Bernardis, Rats clearing a vaginal infection by Candida albicans aquire specific, antibody-mediated resistance to vaginal infection. Infect. Immun., 63: 2619-2624, 1995.
  • P.L. Fidel, Jr., M.E. Lynch, V. Redondo-Lopez, J.D. Sobel, and R. Robinson, Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RWC). J. Infect. Dis., 168: 1458-1465, 1993.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun., 62: 1032-1038, 1994.
  • P.L. Fidel, Jr., M.E. Lynch, D.H. Conaway, L. Tait, and J.D. Sobel, Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect. Immune., 63: 547-553, 1995.
  • P. L. Fidel, Jr., J.L. Cutright, and J.D. Sobel, Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect. Immun., 63: 4191-4194, 1995.
  • P. L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun., 63: 2403-2408, 1995.
  • P.L. Fidel, Jr., N.A. Wolf, and M.A. KuKuruga, T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun., 64: 3793-3799, 1996.
  • L. Polonelli, F. De Bernardis, S. Conti, M. Boccanera, M. Gerloni, G. Morace, W. Magliani, C. Chezzi, and A. Cassone, Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol., 152: 3175-3182, 1994.
  • L. Polonelli, F. De Bernardis, S. Conti, M. Boccanera, W. Magliani, M. Gerloni, C. Cantella, and A. Cassone, Human natural yeast killer toxin-like candidicidal antibodies. J. Immunol., 156: 1880-1885, 1996.
  • F. De Bernardis, M. Boccanera, D. Adriana, E. Spreghini, G. Santoni, and A. Cassone, Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun., 65: 3399-3405, 1997.
  • C. Steele, M. Ratteree, and P.L. Fidel, Jr., Differential susceptibility to experimental vaginal candidiasis in macaques. J. Infect. Dis., 180: 802-810, 1999.
  • D.V. Ehrensaft, R.B. Epstien, S. Sarpel, and B.R. Andersen, Disseminated candidias in leukopenic dogs. Proc. Soc. Exp. Biol. Med., 160: 6-10, 1979.
  • H. W. Holm and R.M. Marwin, Effects of surface active agents on the susceptibility of Swiss mice to Candida albicans. Mycopathol. Mycol. Appl., 33: 186-192, 1967.
  • E. Brummer, J.G. McEwen, and D.A. Stevens, Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: Comparison with murine peripheral blood PMN. Clin. Exp. Immunol., 66: 681-690, 1986.
  • C.J. Morrison, E. Brummer, and D.A. Stevens, Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function: Studies with fungal targets. Cell Immunol., 110: 176-182, 1987.
  • M. Baccarini, F. Bistoni, P. Puccetti, and E. Garaci, Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: Nature of the in vitro cytotoxic effector. Infect. Immun., 42: 1-9, 1983.
  • J.Y. Djeu and D.K. Blanchard, Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J. Immunol., 139: 2761-2767, 1987.
  • L. Romani, S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni, Th1 and Th2 cytokine secretion patterns in murine candidiasis: Association of Th1 responses with acquired resistance. Infect. Immun., 59: 4647-4654, 1991.
  • L. Romani, A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti, and F. Bistoni, CD + subset expression in murine candidiasis. J. Immunol., 150: 925-931, 1993.
  • L. Romani, P. Puccetti, and F. Bistoni, Biological role of Th cell subsets in candidiasis. In S. Romagnani, (Ed.), Th1 and Th2 Cells in Health and Disease, Farmington, CT: Karger, p. 114, 1996.
  • R.S. Klein, C.A. Harris, C.B. Small, B. Moll, M. Lesser, and G.H. Friedland, Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 311: 354-357, 1984.
  • A.M. Macher, The pathology of AIDS. Public Health Report, 103: 246-254, 1988.
  • R.A. Clift, Candidiasis in the transplant patient. Amer. J. Med., 77(Suppl.4D): 34-38, 1984.
  • L. Knight and J. Fletcher, Growth of Candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteriods and diabetes mellitus. J. Infect. Dis., 123: 371-377, 1971.
  • C.H. Kirkpatrick, Chronic mucocutaneous candidiasis. Eur. J. Clin. Microbiol. Infect. Dis., 8: 448-456, 1989.
  • C.H. Kirkpatrick, R.R. Rich, and J.E. Bennett, Chronic mucocutaneous candidiasis: Model building in cellular immunity. Ann. Intern. Med., 75: 955-978, 1971.
  • R.Y. Paterson, R. Semo, G. Blumenschein, and J. Swelstad, Mucocutaneous candidiasis, energy and a plasma inhibitor of cellular immunity: Reversal after amphotericin B therapy. Clin. Exp. Immunol., 9: 595-602, 1971.
  • M.T. Cantorna and E. Balish, Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun., 58: 1093-1100, 1990.
  • E. Balish, H. Filutowicz, and T.D. Oberley, Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun., 58: 107-113, 1990.
  • E. Cenci, A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K.H. Enssle, P. Puc- cetti, L. Romani, and F. Bistoni, T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis., 171: 1279-1288, 1995.
  • T.J. Rogers and E. Balish, Immunity to Candida albicans. Microbiological Rev., 44: 660-682, 1980.
  • A. Ferrante and Y.H. Thong, Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia., 17: 293-297, 1979.
  • K. Kagaya and Y. Fukazawa, Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of Candida albicans. Microbiol. Immunol., 25: 807-818, 1981.
  • M. Yamamura and H. Valdimarsson, Participation of C3 in intracellular of Candida albicans. Scand. J. Immunol. 6: 591-594, 1977.
  • S. Mathur, G. Virella, J. Koistinen, E.O. Horger, TA. Mahvi, and H.H. Fudenberg, Humoral immunity in vaginal candidiasis. Infect. Immun., 15: 287-294, 1977.
  • W.F. Liljemark and R.J. Gibbons, Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect. Immun., 8: 846-849, 1973.
  • R.C. Matthews, J.P. Burnie, and S. Tabaqchali, Immunoblot analysis of the sero- logical response in systemic candidosis. Lancet, 2: 1415-1418, 1984.
  • S.H. E. Kaufmann, Heat shock proteins and the immune response. Immunol. Today, 11(4): 129-136, 1990.
  • Y. Han and J.E. Cutler, Antibody response that protects against disseminated candidiasis. Infect. Immun., 63: 2714-2719, 1995.
  • R.C. Matthews, J.P. Burnie, D. Howat, T. Rowland, and F. Walton, Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology, 74: 20-24, 1991.
  • A. Casadevall, Antibody immunity and invasive fungal infections. Infect. Immun., 63: 4211-4218, 1995.
  • R.F. Hector, J.E. Domer, and E.W. Carrow, Immune responses to Candida albicans in genetically distinct mice. Infect. Immun., 38: 1020-1028, 1982.
  • R.L. Fidel, Jr., W. Luo, J. Chabain, N.A. Wolf, and E. Van Buren, Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect. Immun., 65: 3939-3943, 1997.
  • C.A. Black, F.M. Eyers, A. Russell, M.L. Dunkley, R.L. Clancy, and K.W. Beagley, Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J. Reprod. Immunol., 45: 1-18, 1999.
  • R.D. Mulero-Marchese, K.J. Blank, and T.G. Sieck, Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization. J. Infect. Dis., 178: 227-234, 1998.
  • R.D. Mulero-Marchese, K.J. Blank, and T.G. Sieck, Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization. Immuno- genetics, 49: 973-980, 1999.
  • S.S. Witkin, Inhibition of Conrfirfo-induced lymphocyte proliferation by antibody to Candida albicans. Obstet. Gynecol., 68: 696-699, 1986.
  • S.S. Witkin, J. Hirsch, and W.J. Ledger, A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol., 155: 790-795, 1986.
  • J.R. Hobbs, D. Briden, F. Davidson, M. Kahan, and J.K. Oates, Immunological aspects of candidal vaginitis. Proc. R. Soc. Med., 70: 11-14, 1977.
  • I.W. Fong, P. McCleary, and S. Read, Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am. J. Obstet. Gynecol., 166: 887-890, 1992.
  • R.A. Syverson, H. Buckley, J. Gibian, and J.J. M. Ryan, Cellular and humoral immune status in women with chronic Candida vaginitis. Am. J. Obstet. Gynecol., 134: 624-627, 1979.
  • W. Mendling and U. Koldovsky, Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect. Dis. Obstet. Gynecol., 4, 225-231, 1996.
  • E.M. Corrigan, R.L. Clancy, M.L. Dunkley, F.M. Eyers, and K.W. Beagley, Cellular immunity in recurrent vulvovaginal candidiasis. Clin. Exp. Immunol., 111: 574-578, 1998.
  • D.N. Burns, R. Tuomala, B.H. Chang, R. Hershow, H. Minkoff, E. Rodriquez, C. Zorrilla, H. Hammill, and J. Regan, Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during postpartum period. Clin. Inf. Dis., 24: 201-210, 1997.
  • A. Duerr, M.F. Sierra, J. Feldman, L.M. Clarke, I. Ehlich, and J. Dehovitz, Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet. Gynecol., 90: 252-256, 1997.
  • A. Spinillo, G. Michelone, C. Cavanna, L. Colonna, E. Capuzzo, and S. Nicola, Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin. Med., 70: 268-272, 1994.
  • M.H. White, Is vulvovaginal candidiasis an AIDS-related illness. Clin. Infect. Dis., 22(Suppl. 2): S124-S127, 1996.
  • R.A. Clark, S.A. Blakley, J. Rice, and W. Brandon, Predictors of HIV progression in women. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9: 43-50, 1995.
  • P. Schuman, J.D. Sobel, S. Ohmit, K.H. Mayer, A. Rompalo, A. Duerr, D.K. Smith, D. Warren, and R.S. Klein, Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis., 27: 1161-1167, 1998.
  • J.L. Rhoads, D.C. Wright, R.R. Redfield, and D.S. Burke, Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA, 257: 3105-3107, 1987.
  • N. Imam, C.C. J. Carpenter, K.H. Mayer, A. Fisher, M. Stein, and S.B. Danforth, Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Amer. J. Med., 89: 142-146, 1990.
  • L.P. Samaranayake, Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol., 73: 171-180, 1992.
  • R.L. Fidel, Jr., N.A. Wolf, J.L. Cutright, J.D. Sobel, and P. Schuman, Candidaspecific Thl/Th2 reactivity in HIV+ women with and without vulvovaginal candidiasis. (2000) (Submitted).
  • M.B. Parr and E.L. Parr, Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol., 17: 101-114, 1990.
  • M.B. Parr, L. Kepple, and E.L. Parr, Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol. Reprod., 45: 261-265, 1991.
  • S. Itohara, A.G. Farr, J.J. Lafaille, M. Bonneville, Y. Takagaki, W. Hass, and S. Tonegawa, Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature, 343: 754-757, 1990.
  • D. Nandi and J.P. Allison, Phenotypic analysis and gamma/delta T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol., 147: 1773-1778, 1991.
  • A.R. Ibraghimov, R.E. Sacco, M. Sandor, Z. lakoubov, and R.G. Lynch, Resident CD4+ aß T cells of the murine female genital tract: A phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int. Immunol., 7: 1763-1769, 1995.
  • F. Hladik, G. Lentz, E. Delpit, A. McElroy, and M.J. McElrath, Coexpression of CCR5 and IL-2 in human genital but not blood cells: Implications for the ontogeny of the CCR5 + Thl phenotype. J. Immunol., 163: 2306-2313, 1999.
  • G. Inghirami, B.Y. Zhu, L. Chess, and D.M. Knowles, Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. Amer. J. Pathol., 136: 357-367, 1990.
  • E. -L. Johansson, A. Rudin, L. Wassen, and J. Holmgren, Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology, 96: 272-277, 2000.
  • H.D. White, K.M. Crassi, A.L. Givan, J.E. Stern, J.L. Gonzalez, V.A. Memoli, W.R. Green, and C.R. Wira, CD3 + CDS + CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause. J. Immunol., 158: 3017-3027, 1997.
  • F.L. Wormley, Jr., M. Scott, W. Luo, M. Baker, J. Chaibon, and P.L. Fidel, Jr., Evidence for a unique expression of CD4 on murine CD4+ vaginal cells. Immunology, 2000: 300-308.
  • R.E. Bachelder, J. Bilancieri, W. Lin, and N.L. Letvin, A human recombinant Fab identifies a human immunodeficiency virus type-I induced conformational change in cell-surface-expressed CD4. J. Virol., 69: 5734-5742, 1995.
  • A.M. Michie, J.R. Carlyle, and J.C. Zuniga-Pflucker, Early intrathymic precursor cells acquire a CD4low phenotype. J. Immunol., 160: 1735-1741, 1998.
  • N. Lonberg, S.N. Gettner, E. Lacy, and D.R. Littman, Mouse brain CD4 transcripts encode only the COOH-terminal half of the protein. Mol. Cell. Biol. 8: 2224-2228, 1988.
  • B. Tourvieille, S.D. Gorman, E.H. Field, T. Hunkapiller, and J.R. Parnes, Isolation and sequence of L3T4 complementary DNA clones: Expression in T cells and brain. Science, 234: 610-614, 1986.
  • R. Haars, P. Conradt, I. Miltner, and H. Wagner, A novel form of CD4 (L3T4) mRNA in the murine fetal liver results in cell-surface expression of the L3T4 antigen. Scand. J. Immunol., 34: 253-258, 1991.
  • P.L. Fidel, Jr., F.L. Wormley, Jr., J. Chaibon, R.R. Cresson, and V. Lounev, Analysis of the CD4 protein on human vaginal CD4+ T cells. 2001, Am J Reprod. Immunol. 45: 200-204.
  • E. Rakasz, M. Hagen, M. Sandor, and R.G. Lynch, ?d cells of the murine vagina: T cell response in vivo in the absence of the expression of CD2 and CD28 molecules. Int. Immunol., 9: 161-167, 1997.
  • E. Rakasz, M. Sandor, M. Hagen, and R.G. Lynch, Activation features of intraepithelial ?d T-cells of the murine vagina. Immunology Letters, 54: 129-134, 1996.
  • M.T. Cantoma, D. Mook, and E. Balish, Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun., 58: 3813-3815, 1990.
  • J. Jones-Carson, A. Vazquez-Torres, H.C. van der Heyde, T. Warner, R.D. Wagner, and E. Balish, ?/d T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Medicine, 6: 552-557, 1995.
  • [97a] F.L. Wormley, Jr., C. Steele, K. Wozniak, K. Fujihashi, J.R. McGhee, and P.L. Fidel, Jr. Resistance of TCR d-chain deficient mice to experimental Candida vaginitis. Infect. Immun. 69: 7162-7164, 2001.
  • P.L. Fidel, Jr., W. Luo, C. Steele, J. Chabain, M. Baker, and F.L. Wormley, Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect. Immun., 67: 3135-3140, 1999.
  • T.K. Cain and R.G. Rank, Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun., 63(5): 1784-1789, 1995.
  • K.A. Kelly and R.G. Rank, Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun., 65: 5198-5208, 1997.
  • M.B. Parr and E.L. Parr, Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol., 72: 2677-2685, 1998.
  • M.B. Parr and E.L. Parr, Protective immunity against HSV-2 in the mouse vagina. J. Reprod. Immunol., 36: 77-92, 1997.
  • [102a] K.A. Kelly, H.L. Gray, J.C. Walker, R.G. Rank, F.L. Wormley, Jr., and P.L. Fidel, Jr. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect. Immun., 69: 3451-3454, 2001.
  • M. Saavedra, B. Taylor, N.W. Lukacs, and P.L. Fidel, Jr., Local production of chemokines during experimental vaginal candidiasis. Infect. Immun., 67: 5820-5829, 1999.
  • B.N. Taylor, M. Saavedra, and P.L. Fidel, Jr., Local Thl/Th2 cytokine production during experimental vaginal candidiasis. Med. Mycol. 38: 419-431, 2000.
  • F. Sallusto, A. Lanzavecchia, and C.R. Mackay, Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today, 19: 568-574, 1998.
  • P.L. Fidel, Jr., K.A. Ginsburg, J.L. Cutright, N.A. Wolf, D. Leaman, K. Dunlap, and J.D. Sobel, Vaginal-associated immunity in women with recurrent vulvova- ginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J. Infect. Dis., 176: 728-739, 1997.
  • P. Regulez, J.F. Garcia Fernandez, M.D. Moragues, J. Schneider, G. Quindos, and J. Ponton, Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol. Obstet. Invest., 37: 110-114, 1994.
  • S.S. Witkin, J. Jeremias, and W.J. Ledger, Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J. Med. Vet. Mycol., 27: 57-58, 1989.
  • S.S. Witkin, J. Jeremias, and W.J. Ledger, A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol., 81: 412-416, 1988.
  • M.B. Parr and E.L. Parr, Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod., 44: 491-498, 1991.
  • W.H. Kutteh, Z. Moldoveanu, and J. Mestecky, Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res. Human Retro., 14: 51-55, 1998.
  • C.A. Black, F.M. Eyers, A. Russell, M.L. Dunkley, R.L. Clancy, and K. W Beagley, Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun., 66: 1273-1275, 1998.
  • Y. Sonoda, N. Mukaida, J. Wang, M. Shimada-Hiratsuka, M. Naito, T. Kasahara, A. Harada, M. Inoue, and K. Matsushima, Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine. J. Immunol., 160: 6159-6165, 1998.
  • G. Arancia, A. Molinari, P. Crateri, A. Stringaro, C. Ramoni, M.L. Dupuis, M.J. Gomez, A. Torosantucci, and A. Cassone, Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect. Immun., 63: 280-288, 1995.
  • S.R. Hedges, W.W. Agace, and C. Svanborg, Epithelial cytokine responses and mucosal cytokine networks. Trends in Microbiol., 3: 266-270, 1995.
  • R.A. Fratti, M.A. Ghannoum, J.E. Edwards, Jr., and S.G. Filler, Gamma inter- feron protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect. Immun., 64: 4714-4718, 1996.
  • C. Steele, H. Ozenci, W. Luo, M. Scott, and P.L. Fidel, Jr., Growth inhibition of Candida albicans by vaginal cells from naive mice. J. Med. Mycol., 37: 251-260, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.